Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines



   neurofibromatosis, type 1
  

Disease ID 911
Disease neurofibromatosis, type 1
Synonym
[m]von recklinghausen's disease
clinical von reclinghausen's disease
disease recklinghausens
molluscum fibrosum
neurofibromatoses, peripheral
neurofibromatoses, type i
neurofibromatosis (nonmalignant) type
neurofibromatosis 1
neurofibromatosis 1 (disorder)
neurofibromatosis 1 [disease/finding]
neurofibromatosis a 01
neurofibromatosis i
neurofibromatosis type 1
neurofibromatosis type 1 (nf1)
neurofibromatosis type i
neurofibromatosis, peripheral
neurofibromatosis, peripheral type
neurofibromatosis, peripheral, nf 1
neurofibromatosis, peripheral, nf1
neurofibromatosis, type 1 (disorder)
neurofibromatosis, type 1 [von recklinghausen's disease]
neurofibromatosis, type i
nf1
nf1 (neurofibromatosis 1)
peripheral neurofibromatoses
peripheral neurofibromatosis
phakomatosis recklinghausen
recklinghausen dis of nerve
recklinghausen disease
recklinghausen disease of nerve
recklinghausen disease, nerve
recklinghausen's disease
recklinghausen's disease of nerve
recklinghausen's neurofibromatosis
recklinghausens dis of nerve
recklinghausens disease of nerve
type 1 neurofibromatosis
type 1, neurofibromatosis
type i neurofibromatoses
type i, neurofibromatosis
von recklinghausen dis
von recklinghausen disease
von recklinghausen's disease
von recklinghausens dis
von recklinghausens disease
Orphanet
OMIM
DOID
ICD10
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:173)
C0027830  |  neurofibromas  |  30
C0027830  |  neurofibroma  |  24
C0206728  |  plexiform neurofibroma  |  17
C0751690  |  malignant peripheral nerve sheath tumor  |  16
C0027831  |  von recklinghausen disease  |  16
C0879615  |  stromal tumor  |  10
C0206728  |  plexiform neurofibromas  |  9
C0031511  |  pheochromocytoma  |  8
C0238198  |  gastrointestinal stromal tumor  |  8
C0026654  |  moyamoya  |  7
C0025299  |  meningocele  |  6
C0017601  |  glaucoma  |  5
C0006142  |  breast cancer  |  5
C0026654  |  moyamoya syndrome  |  4
C0238198  |  gastrointestinal stromal tumors  |  4
C0020538  |  hypertension  |  4
C0026654  |  moyamoya disease  |  3
C0036439  |  scoliosis  |  3
C0018552  |  hamartoma  |  3
C0024299  |  lymphoma  |  3
C0027859  |  vestibular schwannoma  |  3
C0017075  |  ganglioneuroma  |  3
C0027809  |  schwannoma  |  3
C0085113  |  neurofibromatosis  |  3
C1619734  |  pulmonary arterial hypertension  |  3
C0020302  |  congenital glaucoma  |  2
C0043324  |  juvenile xanthogranuloma  |  2
C0023343  |  leprosy  |  2
C0022354  |  obstructive jaundice  |  2
C0004114  |  astrocytoma  |  2
C0031511  |  pheochromocytomas  |  2
C0023348  |  lepromatous leprosy  |  2
C0017653  |  glomus tumor  |  2
C0037317  |  sleep disturbance  |  2
C0678222  |  breast carcinoma  |  2
C0003081  |  anisometropia  |  2
C0023418  |  leukemia  |  2
C0014544  |  epilepsy  |  2
C0027859  |  vestibular schwannomas  |  2
C0679466  |  cognitive deficits  |  2
C0022821  |  kyphosis  |  2
C0017636  |  glioblastoma  |  2
C1261473  |  sarcoma  |  2
C0206093  |  primitive neuroectodermal tumor  |  1
C0221355  |  macrocephaly  |  1
C0024221  |  lymphangioma  |  1
C0041408  |  turner syndrome  |  1
C1704214  |  xanthogranuloma  |  1
C0029442  |  osteomalacia  |  1
C1335929  |  schwannomatosis  |  1
C0280783  |  juvenile pilocytic astrocytoma  |  1
C0206754  |  neuroendocrine tumor  |  1
C0017547  |  gigantism  |  1
C0206632  |  angiolipoma  |  1
C0334586  |  pleomorphic xanthoastrocytoma  |  1
C0238033  |  male breast cancer  |  1
C0392525  |  nephrolithiasis  |  1
C0678222  |  carcinoma of breast  |  1
C0014544  |  epileptic seizure  |  1
C0742472  |  central nervous system lymphoma  |  1
C0024302  |  large cell lymphoma  |  1
C0153676  |  lung metastasis  |  1
C0017653  |  glomus tumors  |  1
C0019204  |  hepatocellular carcinoma  |  1
C0162849  |  lichen nitidus  |  1
C0686619  |  lymph node metastases  |  1
C0346326  |  optic nerve glioma  |  1
C0701838  |  malignant schwannoma  |  1
C0022658  |  nephropathy  |  1
C0238432  |  spinal cord ependymoma  |  1
C0018552  |  hamartomas  |  1
C0338106  |  colonic adenocarcinoma  |  1
C0014130  |  endocrine disorders  |  1
C0022658  |  renal disease  |  1
C0206093  |  neuroectodermal tumors  |  1
C0023827  |  liposarcoma  |  1
C0334579  |  anaplastic astrocytoma  |  1
C0740457  |  renal cancer  |  1
C0022661  |  end-stage renal disease  |  1
C0206716  |  ganglioglioma  |  1
C0206180  |  anaplastic large cell lymphoma  |  1
C0042961  |  volvulus  |  1
C0003857  |  arteriovenous malformation  |  1
C0030486  |  paraplegia  |  1
C0037661  |  somatostatinomas  |  1
C0009492  |  compartment syndrome  |  1
C0206695  |  neuroendocrine carcinoma  |  1
C0011644  |  scleroderma  |  1
C0011570  |  depression  |  1
C0019829  |  hodgkin's lymphoma  |  1
C0017605  |  angle closure glaucoma  |  1
C0024305  |  non-hodgkin's lymphoma  |  1
C0002726  |  amyloidosis  |  1
C0003486  |  aortic aneurysm  |  1
C0017653  |  glomus tumour  |  1
C0007104  |  carcinoma of the breast  |  1
C0009319  |  colitis  |  1
C0011334  |  caries  |  1
C0023448  |  lymphoblastic leukemia  |  1
C0007137  |  squamous cell carcinoma  |  1
C0037317  |  sleep disturbances  |  1
C0206655  |  alveolar rhabdomyosarcoma  |  1
C0220603  |  pediatric brain tumor  |  1
C0685938  |  gastrointestinal cancer  |  1
C0178664  |  glomerulosclerosis  |  1
C0017668  |  focal segmental glomerulosclerosis  |  1
C0027766  |  nervous system tumors  |  1
C0040147  |  thyroiditis  |  1
C1861784  |  cerebral cavernous malformations  |  1
C0010346  |  crohn's disease  |  1
C0039538  |  teratoma  |  1
C0024623  |  gastric cancer  |  1
C1261473  |  sarcomas  |  1
C0338106  |  colon adenocarcinoma  |  1
C0022116  |  ischemia  |  1
C0014544  |  epileptic seizures  |  1
C0684249  |  carcinoma of the lung  |  1
C0007115  |  thyroid ca  |  1
C0001418  |  adenocarcinomas  |  1
C0013592  |  ectropion  |  1
C0025202  |  melanoma  |  1
C0020542  |  pulmonary hypertension  |  1
C0221002  |  primary hyperparathyroidism  |  1
C0278883  |  metastatic melanoma  |  1
C0039144  |  syringomyelia  |  1
C0011334  |  dental caries  |  1
C0009806  |  constipation  |  1
C0242379  |  lung cancer  |  1
C0338480  |  migraine without aura  |  1
C0039263  |  atypical coarctation  |  1
C0019937  |  horner's syndrome  |  1
C0005398  |  extrahepatic cholestasis  |  1
C0017609  |  neovascular glaucoma  |  1
C1335309  |  pancreatic mucinous cystadenoma  |  1
C0023470  |  myelogenous leukemia  |  1
C0014556  |  temporal lobe epilepsy  |  1
C0035412  |  rhabdomyosarcoma  |  1
C0879615  |  stromal tumour  |  1
C0034013  |  precocious puberty  |  1
C0154916  |  iris neovascularization  |  1
C0037661  |  somatostatinoma  |  1
C0851578  |  sleep disorders  |  1
C0334583  |  pilocytic astrocytoma  |  1
C0035412  |  rhabdomyosarcomas  |  1
C0852949  |  arteriopathy  |  1
C0037822  |  speech disorders  |  1
C0152013  |  adenocarcinoma of the lung  |  1
C0549473  |  thyroid carcinoma  |  1
C0029408  |  osteoarthritis  |  1
C0041341  |  tuberous sclerosis complex  |  1
C0238463  |  papillary thyroid carcinoma  |  1
C0010635  |  mucinous cystadenoma  |  1
C0009324  |  ulcerative colitis  |  1
C0007113  |  rectal cancer  |  1
C0751265  |  learning disabilities  |  1
C0155550  |  neural deafness  |  1
C0010964  |  dandy-walker malformation  |  1
C0023449  |  acute lymphoblastic leukemia  |  1
C0431399  |  joubert syndrome  |  1
C0020255  |  hydrocephalus  |  1
C0010633  |  cystadenoma  |  1
C0677607  |  hashimoto's thyroiditis  |  1
C0020502  |  hyperparathyroidism  |  1
C0019937  |  horner syndrome  |  1
C0376480  |  gingival enlargement  |  1
C0041341  |  tuberous sclerosis  |  1
C0038379  |  strabismus  |  1
C0021843  |  intestinal obstruction  |  1
C0238198  |  gastrointestinal stromal tumor (gist)  |  1
C0553723  |  cutaneous squamous cell carcinoma  |  1
C0008029  |  cherubism  |  1
C0018784  |  sensorineural deafness  |  1
C0687120  |  nephronophthisis  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:3)
MSH2  |  4436  |  CTD_human
NF1  |  4763  |  CLINVAR;CTD_human;OMIM;ORPHANET;UNIPROT
SPRED1  |  161742  |  CTD_human
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:2)
1029  |  CDKN2A  |  infer
4763  |  NF1  |  infer
Text Mined Gene(Waiting for update.)
Locus(Waiting for update.)
Disease ID 911
Disease neurofibromatosis, type 1
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:137)
HP:0001067  |  Neurofibromas  |  33
HP:0002664  |  Neoplasia  |  29
HP:0009732  |  Plexiform neurofibroma  |  17
HP:0100697  |  Neurofibrosarcoma  |  17
HP:0100723  |  Gastrointestinal stroma tumor  |  10
HP:0002617  |  Aneurysmal dilatation  |  9
HP:0002666  |  Pheochromocytoma  |  8
HP:0003002  |  Breast carcinoma  |  7
HP:0002435  |  Meningocele  |  6
HP:0100543  |  Cognitive deficits  |  5
HP:0004947  |  Arteriovenous fistula  |  5
HP:0000501  |  Glaucoma  |  5
HP:0030731  |  Carcinoma  |  5
HP:0012151  |  Hemothorax  |  5
HP:0009733  |  Glioma  |  4
HP:0000822  |  Hypertension  |  4
HP:0000952  |  Yellow skin  |  3
HP:0009737  |  Lisch nodules  |  3
HP:0009588  |  Vestibular Schwannoma  |  3
HP:0003005  |  Ganglioneuroma  |  3
HP:0002597  |  Abnormality of blood vessels  |  3
HP:0007544  |  Piebaldism  |  3
HP:0010566  |  Hamartoma  |  3
HP:0100008  |  Schwann cell tumour  |  3
HP:0002650  |  Scoliosis  |  3
HP:0002665  |  Lymphoma  |  3
HP:0003764  |  Naevus  |  2
HP:0012803  |  Anisometropia  |  2
HP:0009592  |  Astrocytoma  |  2
HP:0100843  |  Glioblastoma  |  2
HP:0000365  |  Hearing impairment  |  2
HP:0007018  |  Attention deficits  |  2
HP:0000708  |  Behavioral problems  |  2
HP:0002861  |  Melanoma  |  2
HP:0001087  |  Childhood glaucoma  |  2
HP:0002808  |  Gibbus deformity  |  2
HP:0030692  |  Brain tumor  |  2
HP:0001250  |  Seizures  |  2
HP:0001920  |  Renal artery stenosis  |  2
HP:0100242  |  Sarcoma  |  2
HP:0001909  |  Leukemia  |  2
HP:0002277  |  Horner's syndrome  |  2
HP:0100775  |  Dural ectasia  |  2
HP:0002360  |  Sleep disturbance  |  2
HP:0002895  |  Papillary thyroid carcinoma  |  1
HP:0002859  |  Rhabdomyosarcoma  |  1
HP:0000656  |  Ectropion  |  1
HP:0012393  |  Allergy  |  1
HP:0002890  |  Thyroid carcinoma  |  1
HP:0000238  |  Nonsyndromal hydrocephalus  |  1
HP:0000407  |  sensorineural hearing loss  |  1
HP:0002631  |  Ascending aortic aneurysm  |  1
HP:0100026  |  Arteriovenous malformation  |  1
HP:0000572  |  Visual loss  |  1
HP:0002083  |  Migraine without aura  |  1
HP:0008619  |  Bilateral sensorineural hearing impairment  |  1
HP:0000212  |  Gingival overgrowth  |  1
HP:0003418  |  Back pain  |  1
HP:0002092  |  Pulmonary artery hypertension  |  1
HP:0002716  |  Lymph node hyperplasia  |  1
HP:0009792  |  Teratoma  |  1
HP:0002138  |  Subarachnoid hemorrhage  |  1
HP:0009589  |  Bilateral vestibular Schwannoma  |  1
HP:0002315  |  Headaches  |  1
HP:0005086  |  Knee osteoarthritis  |  1
HP:0008200  |  Primary hyperparathyroidism  |  1
HP:0001305  |  Dandy-Walker cyst  |  1
HP:0002888  |  Ependymoma  |  1
HP:0003774  |  End-stage renal failure  |  1
HP:0010787  |  Genital tumor  |  1
HP:0000486  |  Squint eyes  |  1
HP:0000112  |  Nephropathy  |  1
HP:0006721  |  Acute lymphocytic leukemia  |  1
HP:0002751  |  Kyphoscoliosis  |  1
HP:0002583  |  Colitis  |  1
HP:0004586  |  Fish vertebrae  |  1
HP:0003396  |  Syringomyelia  |  1
HP:0012163  |  Carotid artery aneurysm  |  1
HP:0002019  |  Dyschezia  |  1
HP:0010550  |  Paraplegia  |  1
HP:0002860  |  Squamous cell carcinoma  |  1
HP:0002239  |  Gastrointestinal hemorrhage  |  1
HP:0011497  |  New blood vessel formation in iris  |  1
HP:0000090  |  juvenile nephronophthisis  |  1
HP:0000845  |  Acromegalic growth  |  1
HP:0001263  |  Developmental retardation  |  1
HP:0100006  |  Tumors of the central nervous system  |  1
HP:0100324  |  Progressive systemic scleroderma  |  1
HP:0012126  |  Gastric cancer  |  1
HP:0100279  |  Ulcerative colitis  |  1
HP:0006779  |  Alveolar rhabdomyosarcoma  |  1
HP:0000771  |  Gynaecomastia  |  1
HP:0000670  |  Dental caries  |  1
HP:0001824  |  Weight loss  |  1
HP:0002150  |  Hypercalcinuria  |  1
HP:0000097  |  focal glomerulosclerosis  |  1
HP:0000957  |  Cafe-au-lait macules  |  1
HP:0012318  |  Occipital neuralgia  |  1
HP:0004942  |  Aortic aneurysm  |  1
HP:0030065  |  Primitive neuroectodermal tumor  |  1
HP:0010310  |  Chylothorax  |  1
HP:0012189  |  Hodgkin disease  |  1
HP:0012334  |  Extrahepatic cholestasis  |  1
HP:0011034  |  Amyloid disease  |  1
HP:0100646  |  Thyroiditis  |  1
HP:0000826  |  Precocious puberty  |  1
HP:0100280  |  Morbus Crohn  |  1
HP:0002584  |  Intestinal hemorrhage  |  1
HP:0002758  |  Osteoarthritis  |  1
HP:0000256  |  Macrocrania  |  1
HP:0001324  |  Muscular weakness  |  1
HP:0002947  |  Cervical kyphosis  |  1
HP:0000096  |  Glomerulosclerosis  |  1
HP:0100570  |  Carcinoid tumor  |  1
HP:0002580  |  Volvulus  |  1
HP:0000924  |  Abnormality of the skeletal system  |  1
HP:0007716  |  Intraocular melanoma  |  1
HP:0012721  |  Venous malformations  |  1
HP:0005864  |  Pseudoarthroses  |  1
HP:0000843  |  Hyperparathyroidism  |  1
HP:0000938  |  Decreased bone mineral density  |  1
HP:0002573  |  Bloody diarrhea  |  1
HP:0000787  |  Renal calculi  |  1
HP:0002749  |  Osteomalacia  |  1
HP:0012034  |  Liposarcoma  |  1
HP:0005214  |  Bowel obstruction  |  1
HP:0002167  |  Speech disorder  |  1
HP:0009735  |  Spinal neurofibromas  |  1
HP:0001252  |  Hypotonia  |  1
HP:0001342  |  Intracerebral hemorrhage  |  1
HP:0200058  |  Angiosarcoma  |  1
HP:0002827  |  Hip dislocation  |  1
HP:0001402  |  Hepatocellular carcinoma  |  1
HP:0000872  |  Hashimoto's thyroiditis  |  1
HP:0001321  |  Small cerebellum  |  1
HP:0100764  |  Lymphangioma  |  1
HP:0000716  |  Depression  |  1
Disease ID 911
Disease neurofibromatosis, type 1
Manually Symptom(Waiting for update.)
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:63)
C0027830  |  neurofibromas  |  26
C0206727  |  nerve sheath tumor  |  14
C0751690  |  malignant peripheral nerve sheath tumor  |  12
C0206728  |  plexiform neurofibroma  |  10
C0751689  |  peripheral nerve sheath tumors  |  8
C0031511  |  pheochromocytoma  |  7
C0027830  |  neurofibroma  |  7
C0002940  |  aneurysm  |  6
C0017638  |  gliomas  |  6
C0206728  |  plexiform neurofibromas  |  5
C0751690  |  malignant peripheral nerve sheath tumors  |  4
C0017638  |  glioma  |  4
C0024299  |  lymphoma  |  3
C0017075  |  ganglioneuroma  |  3
C0016169  |  fistula  |  3
C0025299  |  meningocele  |  3
C0019080  |  hemorrhage  |  3
C0006142  |  breast cancer  |  3
C0027809  |  schwannomas  |  3
C0238198  |  gastrointestinal stromal tumor  |  3
C0206727  |  nerve sheath tumors  |  3
C0751690  |  malignant peripheral nerve sheath tumour  |  2
C0036439  |  scoliosis  |  2
C0018552  |  hamartoma  |  2
C0679466  |  cognitive deficits  |  2
C0020302  |  congenital glaucoma  |  2
C1619734  |  pulmonary arterial hypertension  |  2
C0037822  |  speech disorders  |  1
C0018944  |  hematoma  |  1
C0155760  |  artery rupture  |  1
C0017075  |  ganglioneuromas  |  1
C0018681  |  headache  |  1
C1608408  |  malignant transformation  |  1
C1384666  |  hearing loss  |  1
C0036572  |  seizures  |  1
C0334586  |  pleomorphic xanthoastrocytoma  |  1
C0677866  |  brainstem tumors  |  1
C0027961  |  primary acquired melanosis  |  1
C0035067  |  renal artery stenosis  |  1
C0013291  |  duodenal neoplasms  |  1
C0034013  |  precocious puberty  |  1
C0017653  |  glomus tumors  |  1
C0085136  |  cns tumors  |  1
C0701838  |  malignant schwannoma  |  1
C0221505  |  brain lesions  |  1
C0879615  |  stromal tumors  |  1
C0003857  |  arteriovenous malformation  |  1
C0024623  |  gastric cancer  |  1
C0238198  |  gastrointestinal stromal tumors  |  1
C0020538  |  hypertension  |  1
C1402315  |  vascular lesions  |  1
C0043324  |  juvenile xanthogranuloma  |  1
C0346057  |  cutaneous neurofibroma  |  1
C0001418  |  adenocarcinomas  |  1
C0025299  |  meningoceles  |  1
C0037661  |  somatostatinoma  |  1
C0221002  |  primary hyperparathyroidism  |  1
C0024305  |  non-hodgkin's lymphoma  |  1
C0346326  |  glioma of optic nerve  |  1
C1393529  |  vascular complications  |  1
C0018188  |  granuloma  |  1
C0020255  |  hydrocephalus  |  1
C0334583  |  pilocytic astrocytoma  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:124)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs113488022231901543845KRASumls:C0027831BeFreeOur findings suggest that RAS pathway activation due to BRAF V600E and KRAS mutations is an important event in a subset of peripheral nerve sheath tumours not related to NF.0.0026384742013BRAF7140753336AT,G,C
rs11348802223190154673BRAFumls:C0027831BeFreeOur findings suggest that RAS pathway activation due to BRAF V600E and KRAS mutations is an important event in a subset of peripheral nerve sheath tumours not related to NF.0.0042671252013BRAF7140753336AT,G,C
rs11348802224335681673BRAFumls:C0027831BeFreeThese tumors have been reported to show increased activity in the mitogen-activated protein kinase pathway from the loss of neurofibromatosis-1 regulation and occasionally from BRAF V600E mutation.0.0042671252014BRAF7140753336AT,G,C
rs121918457213651755781PTPN11umls:C0027831BeFreeLEOPARD syndrome (PTPN11, T468M) in three boys fulfilling neurofibromatosis type 1 clinical criteria.0.0019000932011PTPN1112112488466CT
rs137854550118577524763NF1umls:C0027831UNIPROTNF1 mutations in neurofibromatosis 1 patients with plexiform neurofibromas.0.6702361592002NF11731258500AG
rs137854550NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731258500AG
rs13785455113026084763NF1umls:C0027831UNIPROTAnalysis of mutations at the neurofibromatosis 1 (NF1) locus.0.6702361591992NF11731337430CA
rs137854551NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731337430CA
rs137854552NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731334927CT
rs137854552161177864763NF1umls:C0027831BeFreeGonosomal mosaicism for a nonsense mutation (R1947X) in the NF1 gene in segmental neurofibromatosis type 1.0.6702361592005NF11731334927CT
rs137854553NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731230373TG
rs13785455388073364763NF1umls:C0027831UNIPROTLEOPARD syndrome shows a great clinical overlap with neurofibromatosis type 1 (NF1).0.6702361591996NF11731230373TG
rs13785455490035014763NF1umls:C0027831UNIPROTMutational and functional analysis of the neurofibromatosis type 1 (NF1) gene.0.6702361591997NF11731258406AT
rs137854554NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731258406AT
rs137854556107121974763NF1umls:C0027831UNIPROTMore than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in the NF1 gene.0.6702361592000NF11731235729GA,C
rs137854556NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731235729GA,C
rs137854557NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731214524AG
rs137854557150601244763NF1umls:C0027831UNIPROTAutomated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11-17 distinct from the GAP related domain.0.6702361592004NF11731214524AG
rs137854558NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731214581TC
rs137854558112586254763NF1umls:C0027831UNIPROTExon 10b of the NF1 gene represents a mutational hotspot and harbors a recurrent missense mutation Y489C associated with aberrant splicing.0.6702361591999NF11731214581TC
rs137854559NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731249030CT
rs137854560NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731249093CT
rs137854562124832936899TBX1umls:C0027831BeFreeThree members of a Portuguese family, who exhibited clinical evidence of neurofibromatosis type 1 (NF1), were found to possess different heritable and pathological mutations in their NF1 genes: a 1.5-Mb deletion spanning the entire NF1 gene, a truncating CGA-->TGA transition in exon 22 (R1241X), and a frameshift mutation in exon 29 (5406insT).0.0002714422003NF11731235623CT
rs137854562NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731235623CT
rs137854563NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731201044TC
rs137854563107121974763NF1umls:C0027831UNIPROTMore than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in the NF1 gene.0.6702361592000NF11731201044TC
rs137854564NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731235630TC
rs137854564155204084763NF1umls:C0027831UNIPROTNeurofibromatous neuropathy in neurofibromatosis 1 (NF1).0.6702361592004NF11731235630TC
rs137854565NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731330459GT
rs137854566NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731229146TC,G
rs137854566150601244763NF1umls:C0027831UNIPROTAutomated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11-17 distinct from the GAP related domain.0.6702361592004NF11731229146TC,G
rs137854566125225514763NF1umls:C0027831UNIPROTThese children exhibited a constitutional genetic instability associated with clinical features of de novo neurofibromatosis type 1 (NF1) and early onset of extracolonic cancer.0.6702361592003NF11731229146TC,G
rs142712751125225514763NF1umls:C0027831UNIPROTThese children exhibited a constitutional genetic instability associated with clinical features of de novo neurofibromatosis type 1 (NF1) and early onset of extracolonic cancer.0.6702361592003NF11731223532TC,G
rs149055633107121974763NF1umls:C0027831UNIPROTMore than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in the NF1 gene.0.6702361592000NF11731352319CT
rs199474725150601244763NF1umls:C0027831UNIPROTAutomated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11-17 distinct from the GAP related domain.0.6702361592004NF11731156014AG
rs199474728125225514763NF1umls:C0027831UNIPROTThese children exhibited a constitutional genetic instability associated with clinical features of de novo neurofibromatosis type 1 (NF1) and early onset of extracolonic cancer.0.6702361592003NF11731159083GA
rs199474729118577524763NF1umls:C0027831UNIPROTNF1 mutations in neurofibromatosis 1 patients with plexiform neurofibromas.0.6702361592002NF11731159050CT
rs199474730118577524763NF1umls:C0027831UNIPROTNF1 mutations in neurofibromatosis 1 patients with plexiform neurofibromas.0.6702361592002NF11731227547TC
rs199474731106078344763NF1umls:C0027831UNIPROTThe location and type of mutation within the NF1 gene, and its putative effect at the protein level, do not indicate any relationship to any specific clinical feature of NF1.0.6702361592000NF11731163247TG
rs199474732106078344763NF1umls:C0027831UNIPROTThe location and type of mutation within the NF1 gene, and its putative effect at the protein level, do not indicate any relationship to any specific clinical feature of NF1.0.6702361592000NF11731233115CG,T
rs199474732103367794763NF1umls:C0027831UNIPROTNeurofibromatosis type 1 (NF1) is a dominant disorder caused by mutations in the NF1 gene; approximately 100 NF1 gene mutations have been published.0.6702361591998NF11731233115CG,T
rs199474733102201494763NF1umls:C0027831UNIPROTWe have identified a novel mutation L1425P in exon 25 of the NF1 gene in a 12-year-old boy (clinically diagnosed with NF1 at the age of 7).0.6702361591999NF11731259036TC
rs199474734150601244763NF1umls:C0027831UNIPROTAutomated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11-17 distinct from the GAP related domain.0.6702361592004NF11731163331TC
rs199474735150601244763NF1umls:C0027831UNIPROTAutomated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11-17 distinct from the GAP related domain.0.6702361592004NF11731200503TC
rs199474736150601244763NF1umls:C0027831UNIPROTAutomated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11-17 distinct from the GAP related domain.0.6702361592004NF11731200543AT
rs199474737NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731219072TC
rs199474737150601244763NF1umls:C0027831UNIPROTAutomated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11-17 distinct from the GAP related domain.0.6702361592004NF11731219072TC
rs199474738150601244763NF1umls:C0027831UNIPROTAutomated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11-17 distinct from the GAP related domain.0.6702361592004NF11731225134GA
rs199474740150601244763NF1umls:C0027831UNIPROTAutomated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11-17 distinct from the GAP related domain.0.6702361592004NF11731232092AG
rs199474741150601244763NF1umls:C0027831UNIPROTAutomated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11-17 distinct from the GAP related domain.0.6702361592004NF11731233092TG
rs199474742150601244763NF1umls:C0027831UNIPROTAutomated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11-17 distinct from the GAP related domain.0.6702361592004NF11731235728CG,T
rs199474743150601244763NF1umls:C0027831UNIPROTAutomated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11-17 distinct from the GAP related domain.0.6702361592004NF11731260403AG
rs199474744151464694763NF1umls:C0027831UNIPROTNovel and recurrent mutations in the NF1 gene in Italian patients with neurofibromatosis type 1.0.6702361592004NF11731163367TA
rs199474745107121974763NF1umls:C0027831UNIPROTMore than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in the NF1 gene.0.6702361592000NF11731227527GC
rs199474746107121974763NF1umls:C0027831UNIPROTMore than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in the NF1 gene.0.6702361592000NF11731227536CA
rs199474747107121974763NF1umls:C0027831UNIPROTMore than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in the NF1 gene.0.6702361592000NF11731229155TC
rs199474748125525694763NF1umls:C0027831UNIPROTWe established theoretical conditions for DHPLC analysis of all coding exons and splice junctions of the NF1 gene using the WAVEmaker software version 4.1.40 and screened for mutations a panel of 40 unrelated NF1 patients (25 sporadic and 15 familial), genetically uncharacterized.0.6702361592003NF11731229158GA
rs199474749125525694763NF1umls:C0027831UNIPROTWe established theoretical conditions for DHPLC analysis of all coding exons and splice junctions of the NF1 gene using the WAVEmaker software version 4.1.40 and screened for mutations a panel of 40 unrelated NF1 patients (25 sporadic and 15 familial), genetically uncharacterized.0.6702361592003NF11731229887TG
rs199474750125525694763NF1umls:C0027831UNIPROTWe established theoretical conditions for DHPLC analysis of all coding exons and splice junctions of the NF1 gene using the WAVEmaker software version 4.1.40 and screened for mutations a panel of 40 unrelated NF1 patients (25 sporadic and 15 familial), genetically uncharacterized.0.6702361592003NF11731258502GT
rs199474751125525694763NF1umls:C0027831UNIPROTWe established theoretical conditions for DHPLC analysis of all coding exons and splice junctions of the NF1 gene using the WAVEmaker software version 4.1.40 and screened for mutations a panel of 40 unrelated NF1 patients (25 sporadic and 15 familial), genetically uncharacterized.0.6702361592003NF11731335026GA
rs199474752218388564763NF1umls:C0027831UNIPROTNeurofibroma occurs as isolated or multiple lesions frequently associated with neurofibromatosis type 1 (NF1), a common autosomal dominant disorder affecting 1 in 3500 individuals.0.6702361592011NF11731163376GC
rs199474756107121974763NF1umls:C0027831UNIPROTMore than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in the NF1 gene.0.6702361592000NF11731181482TC
rs199474757107121974763NF1umls:C0027831UNIPROTMore than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in the NF1 gene.0.6702361592000NF11731214530AG
rs199474758107121974763NF1umls:C0027831UNIPROTMore than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in the NF1 gene.0.6702361592000NF11731221854TC
rs199474759107121974763NF1umls:C0027831UNIPROTMore than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in the NF1 gene.0.6702361592000NF11731223464TC
rs199474760107121974763NF1umls:C0027831UNIPROTMore than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in the NF1 gene.0.6702361592000NF11731223470AG
rs199474761107121974763NF1umls:C0027831UNIPROTMore than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in the NF1 gene.0.6702361592000NF11731226517TC
rs199474762107121974763NF1umls:C0027831UNIPROTMore than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in the NF1 gene.0.6702361592000NF11731227254TC,G
rs199474763107121974763NF1umls:C0027831UNIPROTMore than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in the NF1 gene.0.6702361592000NF11731227539AC,T
rs199474764107121974763NF1umls:C0027831UNIPROTMore than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in the NF1 gene.0.6702361592000NF11731232852AG
rs199474765107121974763NF1umls:C0027831UNIPROTMore than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in the NF1 gene.0.6702361592000NF11731235651GC
rs199474766107121974763NF1umls:C0027831UNIPROTMore than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in the NF1 gene.0.6702361592000NF11731265317AG
rs19947477392988294763NF1umls:C0027831UNIPROTSix novel mutations in the neurofibromatosis type 1 (NF1) gene.0.6702361591997NF11731200546AG
rs199474774127464024763NF1umls:C0027831UNIPROTNF1 mutations and clinical spectrum in patients with spinal neurofibromas.0.6702361592003NF11731223455TG
rs199474775127464024763NF1umls:C0027831UNIPROTNF1 mutations and clinical spectrum in patients with spinal neurofibromas.0.6702361592003NF11731229374TC
rs199474776127464024763NF1umls:C0027831UNIPROTNF1 mutations and clinical spectrum in patients with spinal neurofibromas.0.6702361592003NF11731337837CG
rs199474778117350234763NF1umls:C0027831UNIPROTDHPLC was therefore optimised for the rapid screening of the 60 exons and splice junctions of the NF1 gene in patients with NF1.0.6702361592001NF11731227549GC
rs199474779117350234763NF1umls:C0027831UNIPROTDHPLC was therefore optimised for the rapid screening of the 60 exons and splice junctions of the NF1 gene in patients with NF1.0.6702361592001NF11731232825TC
rs199474780117350234763NF1umls:C0027831UNIPROTDHPLC was therefore optimised for the rapid screening of the 60 exons and splice junctions of the NF1 gene in patients with NF1.0.6702361592001NF11731233083TG
rs199474781117350234763NF1umls:C0027831UNIPROTDHPLC was therefore optimised for the rapid screening of the 60 exons and splice junctions of the NF1 gene in patients with NF1.0.6702361592001NF11731258501AG
rs199474782117350234763NF1umls:C0027831UNIPROTDHPLC was therefore optimised for the rapid screening of the 60 exons and splice junctions of the NF1 gene in patients with NF1.0.6702361592001NF11731327583GT
rs199474783117350234763NF1umls:C0027831UNIPROTDHPLC was therefore optimised for the rapid screening of the 60 exons and splice junctions of the NF1 gene in patients with NF1.0.6702361592001NF11731336360GA
rs199474784117350234763NF1umls:C0027831UNIPROTDHPLC was therefore optimised for the rapid screening of the 60 exons and splice junctions of the NF1 gene in patients with NF1.0.6702361592001NF11731343015GA
rs199474785109805454763NF1umls:C0027831UNIPROTNF1 gene analysis focused on CpG-rich exons in a cohort of 93 patients with neurofibromatosis type 1.0.6702361592000NF11731229145CT
rs199474786125225514763NF1umls:C0027831UNIPROTThese children exhibited a constitutional genetic instability associated with clinical features of de novo neurofibromatosis type 1 (NF1) and early onset of extracolonic cancer.0.6702361592003NF11731229308TC
rs19947478779816794763NF1umls:C0027831UNIPROTNeurofibromatosis type-1 (NF-1) is an autosomal dominant disorder, caused by mutations in the NF-1 gene.0.6702361591994NF11731233002GA
rs19947478879816794763NF1umls:C0027831UNIPROTNeurofibromatosis type-1 (NF-1) is an autosomal dominant disorder, caused by mutations in the NF-1 gene.0.6702361591994NF11731258489AG
rs199474789NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731258401CT
rs19947479090035014763NF1umls:C0027831UNIPROTMutational and functional analysis of the neurofibromatosis type 1 (NF1) gene.0.6702361591997NF11731258488AC
rs19947479191013004763NF1umls:C0027831UNIPROTNovel and recurrent mutations in the neurofibromatosis type 1 (NF1) gene.0.6702361591997NF11731334879TC
rs19947479221142204763NF1umls:C0027831UNIPROTA major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations.0.6702361591990NF11731334883TC
rs199474792NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731334883TC
rs19947479385441904763NF1umls:C0027831UNIPROTCharacterisation of germline mutations in the neurofibromatosis type 1 (NF1) gene.0.6702361591995NF11731357290AG
rs267606595NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731334933AT
rs267606596NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731327741-C
rs267606597NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731327758-T
rs267606598NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731337514TA
rs267606599NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731230383GA,T
rs267606600NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731219018AG-
rs267606602NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731221842AG
rs267606603NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731201486GA
rs267606604NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731336328AG
rs267606605NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731327699-T
rs267606606NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731229954AAT-
rs267606990194494075781PTPN11umls:C0027831BeFreeThe patient was found to carry a de novo PTPN11 mutation p.T2I as well as the maternally inherited NF1 mutation c.4661+1G>C. Her otherwise healthy mother and brother, who also had the NF1 mutation, showed few café-au-lait spots as the only sign of neurofibromatosis.0.0019000932009PTPN11;RPL612112419116CT
rs386626619186232213717JAK2umls:C0027831BeFreeJAK2 V617F positive polycythemia Vera in a child with neurofibromatosis type I.0.0002714422008NANANANANA
rs397514640174066425080PAX6umls:C0027831BeFreeA novel PAX6 missense mutation (p.R38W) was inherited from her mother whose iris phenotype had not been evident because of ocular neurofibromatosis.0.0002714422007PAX61131802733GA
rs397514641NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731169985CT
rs63750899151390044292MLH1umls:C0027831BeFreeHNPCC mutation MLH1 P648S makes the functional protein unstable, and homozygosity predisposes to mild neurofibromatosis type 1.0.0016286512004MLH1337048562CT
rs768638173NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731226474CT
rs771529172NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731327719GA,C,T
rs772295894NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731338739CA,G
rs77375493186232213717JAK2umls:C0027831BeFreeJAK2 V617F positive polycythemia Vera in a child with neurofibromatosis type I.0.0002714422008JAK2;INSL695073770GA,T
rs786201367NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731357308CT
rs786203390NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731260484GC,T
rs786204059NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731223504AG-
rs786204154NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731227260GCATTGA-
rs786204157NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731259039AG
rs786204207NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731258504TC
rs786204211NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731232879TA
rs786204251NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731232841ACTC-
rs786204253NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731233005TG
rs786204255NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731223455-T
rs797045139NA4763NF1umls:C0027831CLINVARNA0.670236159NANF11731327718CA,G,T
GWASdb Annotation(Total Genotypes:1)
Chr Pos SNP_Id RefGene EnsemblGene ENCODE_Factor ENCODE_TFBS Chromosome_interaction GTEx_eQTL SNP_TFBS_affinity_GWAS3D SNP_miRNA_target_affinity_PolymiRTS SNP_splicing_effect_Skippy SNP_splicing_effect_MutPred_Splice SNP_ns_protein_effect_dbNSFP SNP_syn_effect_Silva SNP_phosphorylation_effect_PhosSNP PhastCons_score PhyloP_score GERP++_RS Segway_state Ancestral_allele ESP_AF ESP_AFR ESP_AFR ESP_EUR TG_ASN TG_AMR TG_AFR TG_EUR Type Consequence bStatistic EncH3K27Ac EncH3K4Me1 EncH3K4Me3 EncNucleo OMIM Clinvar
1732923347rs11080287NM_207313,TMEM132EENST00000321639,ENSG00000181291NANANANABapx1_2343,1.3213Cep3-primary,31.738Cgd2_3490,5.163Cha4-primary,3.1736Mcm1-primary,4.1002NANANANANANA0.000-1.147-4.78TF1ANANANA0.1600.0600.1600.2600.180TranscriptINTRONIC8942.003.00
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Chemical(Total Drugs:0)
(Waiting for update.)
FDA approved drug and dosage information(Total Drugs:0)
(Waiting for update.)
FDA labeling changes(Total Drugs:0)
(Waiting for update.)